Critical Risk Assessment, Diagnosis, and Survival Analysis of Breast Cancer
View abstract on PubMed
Summary
This summary is machine-generated.This study uses machine learning to predict breast cancer risk, diagnose it, and analyze survivability using three datasets. Machine learning models, particularly Random Forest and K-Nearest Neighbor, show promise in improving breast cancer detection and understanding.
Area Of Science
- Oncology and Bioinformatics
- Computational Biology and Data Science
Background
- Breast cancer is a leading cancer in women, necessitating improved risk assessment and early detection strategies.
- Personalized medicine approaches are crucial for effective breast cancer management, acknowledging disease heterogeneity.
Purpose Of The Study
- To develop a breast cancer risk prediction model using the Breast Cancer Surveillance Consortium (BCSC) Risk Factor Dataset.
- To diagnose breast cancer utilizing the Breast Cancer Wisconsin diagnostic dataset.
- To analyze breast cancer survivability with the Surveillance, Epidemiology, and End Results (SEER) Breast Cancer Dataset.
Main Methods
- Applied various pre-processing techniques, including principal component analysis (PCA) and resampling strategies (e.g., Tomek Link).
- Evaluated multiple machine learning classifiers such as Random Forest and K-Nearest Neighbor.
- Conducted survival analysis using supervised and unsupervised learning on the SEER dataset.
Main Results
- Random Forest achieved 87.53% accuracy on the BCSC dataset; Tomek Link resampling improved test accuracy to 87.47%.
- K-Nearest Neighbor reached 94.71% accuracy on the original Wisconsin dataset and 95.29% on the PCA-transformed dataset for diagnosis.
- Survival analysis provided insights into factors influencing breast cancer patient outcomes.
Conclusions
- Machine learning models, especially Random Forest and K-Nearest Neighbor, demonstrate significant potential in breast cancer risk prediction, diagnosis, and survival analysis.
- Data-driven insights and advanced analytical techniques are vital for advancing personalized breast cancer medicine.
- The study highlights the importance of individualized approaches in breast cancer management by considering phenotypic variations.
Related Concept Videos
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
Survival Times Are Positively Skewed
Survival times often exhibit positive skewness, unlike the normal distribution assumed...
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...

